0001400118-13-000001.txt : 20130627
0001400118-13-000001.hdr.sgml : 20130627
20130626213503
ACCESSION NUMBER: 0001400118-13-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20130627
DATE AS OF CHANGE: 20130626
EFFECTIVENESS DATE: 20130627
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: 3-V Biosciences, Inc.
CENTRAL INDEX KEY: 0001400118
IRS NUMBER: 205991472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-198677
FILM NUMBER: 13935811
BUSINESS ADDRESS:
STREET 1: 1050 HAMILTON COURT
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 320-1760
MAIL ADDRESS:
STREET 1: 1050 HAMILTON COURT
CITY: MENLO PARK
STATE: CA
ZIP: 94025
D
1
primary_doc.xml
X0706
D
LIVE
0001400118
3-V Biosciences, Inc.
1050 HAMILTON COURT
MENLO PARK
CA
CALIFORNIA
94025
(650) 320-1760
DELAWARE
None
None
Corporation
true
Merdad
Parsey
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Executive Officer
Director
Beth
Seidenberg
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
Ari
Helenius
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
Gordon
Ringold
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
Robert
Garland
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
David
Mott
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
James
Young
c/o 3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park
CA
CALIFORNIA
94025
Director
Biotechnology
Decline to Disclose
- 06
false
2013-06-14
true
true
true
true
false
0
20376959
7504260
12872699
The total offering amount includes the purchase price of the Series C Preferred Stock, the purchase price of the Common Stock Warrants and the potential proceeds from the exercise of the Common Stock Warrants.
false
2
0
0
0
The proceeds will be used for working capital.
false
3-V Biosciences, Inc.
/s/ Merdad Parsey, MD, Ph.D
Merdad Parsey, MD, Ph.D
Chief Executive Officer
2013-06-26